House Health and Welfare Committee introduces eight health-related RS bills, including Medicaid safeguards and enhanced breast‑cancer screening

The House Health and Welfare Committee introduced eight request‑statements (RS) during a committee meeting, voting to introduce each for a possible full hearing. The measures cover blood‑donor disclosure of mRNA vaccination status (RS32129); an interstate dietitian licensure compact (RS32071); moving existing tobacco rules from IDAPA into statute (RS32009); expanded coverage for enhanced breast‑cancer screening for certain high‑risk patients (RS32127); limits on some nonemergency benefits for people in the country unlawfully (RS31926); additional reporting requirements for 340B covered entities (RS32135); adding mifepristone and mifepristol to the state prescription monitoring regime (RS32165); and a package of Medicaid “safeguards” tied to waivers and program changes (RS32155). All eight motions to introduce carried on voice votes.

The most discussed items in committee were RS32127, which would require coverage of enhanced screening (MRI, contrast mammography or ultrasound) for a subset of women for whom standard mammography is inadequate, and RS32155, a set of measures the sponsor described as “safeguards” for Idaho’s Medicaid expansion that include waiver requests and limits for some able‑bodied adults. Representative Rubel, the bill sponsor on the screening proposal, said a portion of Idaho’s late‑stage breast cancer diagnoses are higher than the national average and argued enhanced screening could detect cancer earlier. “The enhanced screening is about $500 per person,” Rubel said, adding that later‑stage care can cost “1 to $300,000.”

Representative Jordan Redmond introduced several measures, including RS32135 (340B transparency) and RS32165 (moving mifepristone and mifepristol to Schedule IV so they report to the Prescription Drug Monitoring Program). On RS32135 he said the bill would add annual reporting by 340B covered entities to the Department of Health and Welfare, the Idaho Attorney General and the Idaho State Comptroller and that last year he had run a 340B bill that did not pass. On RS32165 he emphasized that the change would allow reporting to the PDMP and said it would not prevent medically necessary uses of those drugs.

Other presenters described narrower or technical proposals. Representative Bruce summarized RS32129 as a measure that would require blood donors to disclose whether they had received an mRNA vaccination and to have that status conspicuously marked on donated blood so receiving clinicians could request blood from donors without that status. Representative Lucas Kaler described RS32071 as establishing a dietitian licensure compact to facilitate practice across state lines; he said Idaho already participates in other health licensure compacts and that several states have pending compact legislation. Representative Rob Bieswanger presented RS32009, which moves IDAPA chapters on minors’ access to tobacco and indoor smoking into statute without adding new taxes or requirements and flagged follow‑up questions on whether the draft addressed synthetic nicotine pouch products.

Committee members generally voted to introduce the RS items but asked for fuller information at a subsequent full hearing on several measures. Questions included requests for fiscal and implementation details for RS32071 (administrative costs to the regulatory licensing body), RS32127 (state fiscal impacts and clinical evidence), RS32165 (effects on medical education and monitoring costs), and RS32155 (how proposed waiver triggers, lifetime limits and work‑requirement implementation would be staffed and administered). Representative McCann and others requested clarity on the mechanics of eligibility determinations and the potential administrative FTE and systems work needed to carry out work requirements or lifetime limits. Representative Redmond said he would bring additional details at a full hearing and that he had discussed waiver strategy with federal officials.

Votes at a glance

- RS32129 (blood‑donor mRNA disclosure): introduced (motion carried, voice vote). Sponsor: Representative Bruce. Summary: donor disclosure of mRNA vaccination status; asked to be printed for hearing.

- RS32071 (dietitian licensure compact): introduced (motion carried, voice vote). Sponsor: Representative Lucas Kaler. Summary: creates interstate compact for dietitian licensure to improve portability and access.

- RS32009 (codify tobacco rules): introduced (motion carried, voice vote). Sponsor: Representative Rob Bieswanger. Summary: moves IDAPA 16.07.25 and IDAPA 16.02.23 into statute; no new fees or taxes specified.

- RS32127 (enhanced breast‑cancer screening coverage): introduced (motion carried, voice vote). Sponsor: Representative Rubel. Summary: requires coverage for enhanced screening for high‑risk patients; fiscal note and clinical impact to be examined at hearing.

- RS31926 (limits on nonemergency benefits for people here unlawfully): introduced (motion carried, voice vote). Sponsor: Representative Jordan Redmond. Summary: leaves emergency care in place but removes some nonemergency health and social benefits for people in the country unlawfully.

- RS32135 (340B transparency): introduced (motion carried, voice vote). Sponsor: Representative Jordan Redmond. Summary: requires annual reporting by 340B covered entities to Idaho agencies; sponsor said Department of Health and Welfare is prepared to receive data.

- RS32165 (add mifepristone and mifepristol to Schedule IV reporting): introduced (motion carried, voice vote). Sponsor: Representative Jordan Redmond. Summary: adds two drugs to the state’s reporting list so usages are visible in the Prescription Drug Monitoring Program; sponsor said it would not bar medically necessary use.

- RS32155 (Medicaid safeguards and waiver framework): introduced (motion carried, voice vote). Sponsor: Representative Jordan Redmond. Summary: establishes guardrails and potential triggers tied to waivers and program changes for Medicaid expansion; fiscal savings estimates were discussed in the RS text and commenters asked for fuller fiscal accounting and implementation details at a hearing.

Committee business concluded with the chair noting there may be additional RS filings and that the committee will schedule hearings to consider the introduced measures. The meeting adjourned after the eight RS items were introduced and the committee discussed scheduling next steps.